The CH2 domain is a critical element of the human Immunoglobulin G (IgG) constant region. Although least stable in IgG, it also promising scaffold candidate for developing novel therapeutic approaches. Recently, we succeeded preparing glycosylated and non-glycosylated host organism Pichia pastoris. Herein, verified that glycosylation decreased both, its tendency to aggregate immunogenicity mice...
